Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Archie Bleyer

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2011
Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trialsCharles D Blanke, Brian M Bot, David M Thomas, et al.
Investigational New Drugs|May 10, 2006
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinomaJaffer A Ajani, Yixing Jiang, Josephine Faust, et al.
Leukemia & Lymphoma|January 11, 2019
Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4<sup>.</sup>Reuven J Schore, Meenakshi Devidas, Archie Bleyer, et al.
Blood|February 4, 2010
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trialLinda C Stork, Yousif Matloub, Emmett Broxson, et al.
The Oncologist|October 29, 2017
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate ClearanceLaura B Ramsey, Frank M Balis, Maureen M O'Brien, et al.
Journal of the National Cancer Institute|May 28, 2010
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trialCharles Lu, J Jack Lee, Ritsuko Komaki, et al.
Leukemia & Lymphoma|December 16, 2006
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144PPaul C Nathan, Trish Whitcomb, Pamela L Wolters, et al.
Cancer|February 6, 2016
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaJames V Tricoli, Donald G Blair, Carey K Anders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysisMarnie Collins, Miriam Wilhelm, Rachel Conyers, et al.
Pediatric Blood & Cancer|February 11, 2023
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use itPenelope Brock, Annelot Meijer, Per Kogner, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2011
Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trialsCharles D Blanke, Brian M Bot, David M Thomas, et al.
Investigational New Drugs|May 10, 2006
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinomaJaffer A Ajani, Yixing Jiang, Josephine Faust, et al.
Leukemia & Lymphoma|January 11, 2019
Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4<sup>.</sup>Reuven J Schore, Meenakshi Devidas, Archie Bleyer, et al.
Blood|February 4, 2010
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trialLinda C Stork, Yousif Matloub, Emmett Broxson, et al.
The Oncologist|October 29, 2017
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate ClearanceLaura B Ramsey, Frank M Balis, Maureen M O'Brien, et al.
Journal of the National Cancer Institute|May 28, 2010
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trialCharles Lu, J Jack Lee, Ritsuko Komaki, et al.
Leukemia & Lymphoma|December 16, 2006
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144PPaul C Nathan, Trish Whitcomb, Pamela L Wolters, et al.
Cancer|February 6, 2016
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaJames V Tricoli, Donald G Blair, Carey K Anders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysisMarnie Collins, Miriam Wilhelm, Rachel Conyers, et al.
Pediatric Blood & Cancer|February 11, 2023
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use itPenelope Brock, Annelot Meijer, Per Kogner, et al.
Pageof 16